Clinical Trial Update: Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial evaluating nasal Foralumab in non-active secondary progressive multiple sclerosis, which is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Foralumab Nasal (Foralumab)

Snippet

Sponsor: Tiziana Life Sciences LTD | Conditions: Non-Active Secondary Progressive Multiple Sclerosis | Phase 2 | Status: RECRUITING